Latest filing published 23 Jun 2022 for TELA Bio, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +30.2%Entry US$12.68 · Close at T+365 US$16.51
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Quaker BioVentures II LP: trading record in brief
Filings by Quaker BioVentures II LP span 5 companies, the busiest being Achillion Pharmaceuticals Inc, Nupathe Inc. and TELA Bio, Inc. The record holds 21 filings, for trades running from 11 August 2010 to 2 June 2022.
Both buying and selling appear: 2 purchases worth €3.2M, against 7 sales worth €2.4M. Taken together, the purchases exceed the sales by €806k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.
The record was last updated on 23 June 2022 with a transaction in TELA Bio, Inc. The latest purchase dates back some time: it was published 2,552 days ago, on 13 November 2019. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Quaker BioVentures II LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,751,100 shares0Common StockSEC:0001104659-22-073703:0
- 516,947 sharesCommon StockSEC:0001192482-19-000430:2
- 345,489 sharesCommon StockSEC:0001192482-19-000430:1
- 153,846 shares@ US$13.00100.0% of flowCommon StockSEC:0001192482-19-000430:0Canonical exit: 6 Feb 2020 (T+90)
- 265,000 shares@ US$7.00Common StockSEC:0001192482-13-000154:0Canonical exit: 17 Sept 2013 (T+90)
- 2,500,000 shares@ US$2.00Common StockSEC:0001192482-13-000068:0
- 546,198 shares@ US$0.01Common StockSEC:0001192482-12-000229:0
- 208,334 shares0Common StockSEC:0001192482-12-000221:0
- 200,822 shares@ US$5.99Common StockSEC:0001192482-11-000051:0
- 100,000 shares@ US$5.88Common StockSEC:0001192482-11-000046:0
- 57,500 shares@ US$5.90Common StockSEC:0001192482-11-000046:1
- 66,300 shares@ US$5.92Common StockSEC:0001192482-11-000046:2
- 75,000 shares@ US$5.07Common StockSEC:0001192482-11-000041:0
- 75,000 shares@ US$5.08Common StockSEC:0001192482-11-000041:1
- 6,787 shares@ US$5.08Common StockSEC:0001192482-11-000041:2
- 1,827,208 sharesCommon StockSEC:0001209191-10-042446:1
- 286,116 sharesCommon StockSEC:0001209191-10-042446:3
- 205,763 sharesCommon StockSEC:0001209191-10-042446:4
18 of 18 declarations
